<p>The proportion of patients with a detectable viral load (≥400 copies/ml) at study visits using three viral load assays (Cavidi reverse transcriptase (RT) assay, Roche RNA PCR, and branched DNA assay [bDNA]).</p
<p>A. Distribution of CD4 cell count; B. HIV viral load by RNA PCR; C. HIV viral load by branched DN...
*<p>Viral Load expressed as log<sub>10</sub> cDNA equivalents/mL of patient plasma.</p><p>ND, not de...
<p>Quantitative detection of total and defective HCV RNA in a subset of patients who carried defecti...
<p>Number of RRT-PCR influenza A virus positive samples and average daily viral load (expressed in L...
<p>Proportion of patients with HIV-1 RNA < 50 copies/mL (ITT FDA snapshot analysis) at weeks 48, 96 ...
A) all positive patients; B) positive patients with viral loads ≥106 copies/ml by any PCR (supposedl...
To explore whether an assay change was responsible for an increasing proportion of patients with und...
<p>Proportion of subjects with plasma HIV-1 RNA<48 copies/mL and <200 copies/mL using the Intention-...
<p>(RT = Cavidi reverse transcriptase (RT) assay, Roche RNA PCR, and bDNA = branched DNA assay).</p
Number of patients positive by RDT (in red) and nasopharyngeal PCR (in blue) and sensitivity of RDT ...
<p>Proportion of samples with positive detection of D222G/N quasispecies in patients with positive v...
Proportion of responders with HIV-1 RNA <40 copies/mL (Week 24 snapshot) (mITT).</p
a<p>Viral load was measured by the Amplicor HIV-1 monitor ultrasensitive Method (Roche), with a dete...
<p>Three patient groups, complete response with viral load <50 copies/ml, partial response with vira...
INTRODUCTION:To explore whether an assay change was responsible for an increasing proportion of pati...
<p>A. Distribution of CD4 cell count; B. HIV viral load by RNA PCR; C. HIV viral load by branched DN...
*<p>Viral Load expressed as log<sub>10</sub> cDNA equivalents/mL of patient plasma.</p><p>ND, not de...
<p>Quantitative detection of total and defective HCV RNA in a subset of patients who carried defecti...
<p>Number of RRT-PCR influenza A virus positive samples and average daily viral load (expressed in L...
<p>Proportion of patients with HIV-1 RNA < 50 copies/mL (ITT FDA snapshot analysis) at weeks 48, 96 ...
A) all positive patients; B) positive patients with viral loads ≥106 copies/ml by any PCR (supposedl...
To explore whether an assay change was responsible for an increasing proportion of patients with und...
<p>Proportion of subjects with plasma HIV-1 RNA<48 copies/mL and <200 copies/mL using the Intention-...
<p>(RT = Cavidi reverse transcriptase (RT) assay, Roche RNA PCR, and bDNA = branched DNA assay).</p
Number of patients positive by RDT (in red) and nasopharyngeal PCR (in blue) and sensitivity of RDT ...
<p>Proportion of samples with positive detection of D222G/N quasispecies in patients with positive v...
Proportion of responders with HIV-1 RNA <40 copies/mL (Week 24 snapshot) (mITT).</p
a<p>Viral load was measured by the Amplicor HIV-1 monitor ultrasensitive Method (Roche), with a dete...
<p>Three patient groups, complete response with viral load <50 copies/ml, partial response with vira...
INTRODUCTION:To explore whether an assay change was responsible for an increasing proportion of pati...
<p>A. Distribution of CD4 cell count; B. HIV viral load by RNA PCR; C. HIV viral load by branched DN...
*<p>Viral Load expressed as log<sub>10</sub> cDNA equivalents/mL of patient plasma.</p><p>ND, not de...
<p>Quantitative detection of total and defective HCV RNA in a subset of patients who carried defecti...